IL134627A0 - Method of protecting against chronic infections - Google Patents

Method of protecting against chronic infections

Info

Publication number
IL134627A0
IL134627A0 IL13462798A IL13462798A IL134627A0 IL 134627 A0 IL134627 A0 IL 134627A0 IL 13462798 A IL13462798 A IL 13462798A IL 13462798 A IL13462798 A IL 13462798A IL 134627 A0 IL134627 A0 IL 134627A0
Authority
IL
Israel
Prior art keywords
protecting against
chronic infections
against chronic
infections
protecting
Prior art date
Application number
IL13462798A
Other languages
English (en)
Original Assignee
Eng Hong Lee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eng Hong Lee filed Critical Eng Hong Lee
Publication of IL134627A0 publication Critical patent/IL134627A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/012—Coccidia antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL13462798A 1997-08-20 1998-08-20 Method of protecting against chronic infections IL134627A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002213385A CA2213385A1 (en) 1997-08-20 1997-08-20 Method of protecting against coccidiosis infections in poultry
PCT/CA1998/000791 WO1999008704A1 (en) 1997-08-20 1998-08-20 Method of protecting against chronic infections

Publications (1)

Publication Number Publication Date
IL134627A0 true IL134627A0 (en) 2001-04-30

Family

ID=4161288

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13462798A IL134627A0 (en) 1997-08-20 1998-08-20 Method of protecting against chronic infections

Country Status (10)

Country Link
US (4) US6306385B1 (pt)
EP (1) EP1005364A1 (pt)
JP (1) JP2001515049A (pt)
CN (1) CN1272793A (pt)
AU (1) AU740407B2 (pt)
BR (1) BR9811319A (pt)
CA (1) CA2213385A1 (pt)
EA (1) EA003749B1 (pt)
IL (1) IL134627A0 (pt)
WO (1) WO1999008704A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6627205B2 (en) * 1997-12-01 2003-09-30 Pfizer Incorporated Ovo vaccination against coccidiosis
US6984378B1 (en) * 1999-02-26 2006-01-10 Pfizer, Inc. Method for the purification, recovery, and sporulation of cysts and oocysts
DE60237977D1 (de) 2001-08-30 2010-11-25 Embrex Inc Verbesserte verfahren zur herstellung von oozysten
US7250286B2 (en) * 2002-05-21 2007-07-31 Schering-Plough Corporation Methods for the in vitro culture of Sporozoea sp. and uses thereof
CA2738682A1 (en) 2004-04-15 2005-10-15 Eng-Hong Lee Soft gel delivery system for treating poultry
DE102006038292A1 (de) * 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
US20080131463A1 (en) * 2006-11-30 2008-06-05 Perdue Holdings, Inc. Vaccination method for controlling coccidiosis in fowl
MX2010012869A (es) * 2008-05-29 2010-12-14 Intervet Int Bv Vacunas contra coccidiosis.
MX2011005133A (es) * 2008-11-13 2011-08-04 Intervet Int Bv Vacuna contra eimeria para pavos.
US11000580B2 (en) 2010-12-27 2021-05-11 Eng Hong Lee Roadmap for controlling malaria
EP2748300B1 (en) 2011-08-24 2018-09-19 DuPont Nutrition Biosciences ApS Enzyme producing bacillus strains
HUE059179T2 (hu) * 2012-09-10 2022-10-28 Galenbio Inc Vízimadárban Mycoplasma-fertõzés megelõzésére szolgáló oltóanyag
US10905136B2 (en) 2015-08-14 2021-02-02 Clear H2O, Inc. High throughput process for delivering semi-firm gel for poultry
CN108553640A (zh) * 2018-06-13 2018-09-21 佛山市正典生物技术有限公司 一种鸡球虫病弱毒活疫苗及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1204057A (en) 1982-06-22 1986-05-06 Eng-Hong Lee Immunization against coccidiosis
US5187080A (en) * 1984-06-05 1993-02-16 Solvay & Cie S.A. DNA encoding an antigenic protein derived from Eimeria tenella and vaccines for prevention of coccidiosis caused by Eimeria tenella
NZ221560A (en) 1986-08-28 1989-10-27 Lilly Co Eli Method of protecting animals against coccidiosis by the oral administration of infective coccidial organisms
US4935007A (en) 1986-08-28 1990-06-19 Eli Lilly And Company Anticoccidial method
US5968914A (en) * 1987-10-28 1999-10-19 Pro-Neuron, Inc. Treatment of chemotherapeutic agent and antiviral agent toxicity with acylated pyrimidine nucleosides
EP0594743B1 (en) 1991-07-12 1999-09-22 Pfizer Inc. Continuous cell line and vaccine against avian coccidia
CA2098773C (en) 1993-06-18 1999-09-21 Eng-Hong Lee Recombinant coccidia and its use in a vaccine
BR9607462A (pt) 1995-02-21 1997-12-23 Lee Eng Hong Vacina viva em forma de gel

Also Published As

Publication number Publication date
EP1005364A1 (en) 2000-06-07
US20060093627A1 (en) 2006-05-04
US20020061314A1 (en) 2002-05-23
BR9811319A (pt) 2001-11-20
US20050226897A1 (en) 2005-10-13
AU8848498A (en) 1999-03-08
CN1272793A (zh) 2000-11-08
EA200000152A1 (ru) 2000-10-30
EA003749B1 (ru) 2003-08-28
CA2213385A1 (en) 1999-02-20
US6306385B1 (en) 2001-10-23
WO1999008704A1 (en) 1999-02-25
AU740407B2 (en) 2001-11-01
JP2001515049A (ja) 2001-09-18

Similar Documents

Publication Publication Date Title
PL327446A1 (en) Protected port interface
PL327569A1 (en) Promedications of thrombosin inhibitors
IL140500A0 (en) Blast effects suppression system
AU3895595A (en) Methods of inhibiting conditions associated with neuropeptide
GB2321641B (en) Sulfamide-metalloprotease inhibitors
PL340838A1 (en) Application of the renin-angiotensin system inhibitors
IL134627A0 (en) Method of protecting against chronic infections
PL325013A1 (en) Profile endopepsidase inhibitors
HU9503783D0 (en) Squvalen syntetase inhibitors
AU2041895A (en) Liquid-resistant protective layer
HK1046359A1 (en) Neuraminidase inhibitors
GB9612990D0 (en) Compositions and methods for the treatment of chronic infections
GB2326192B (en) Protection system
GB9514272D0 (en) Method of protection against tropical cyclones
AU7108998A (en) Method for treating fungal infections
GB9513604D0 (en) Surface protection aid
TW364362U (en) Improvement on structure of protection mouth-muffle
PL103298U1 (en) Protective corner insert
GB9620804D0 (en) Surface protection
PL106430U1 (en) Method of protecting human bodies against bodies undesirable effects of electrostatic field
PL57613Y1 (en) Protective suit
GB2302280B (en) Work of art protection
PL107143U1 (en) Rollerway
HU9600024D0 (en) Protection against window-breakage
GB9727371D0 (en) Inhibitors

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees